BASF SE, the German multinational chemical company, has been consistently making moves throughout the market. They have signed a
10-year gas deal and marked advancements in the
biopharma and
pharmaceutical industries via new investments in North America. The company had a notable stock jump of
10.9%, however, the future outlook remains uncertain as JPMorgan cuts their stock rating and slashed the price target. BASF scores major deals and has seen a rally in stock, but weak financial prospects are dragging down. In addition, BASF is all set to launch Sokalan CP 301 readily biodegradable dispersants, adding to its sustainable personal care solutions. They plan to acquire Full Ownership of Alsachimie Joint Venture and announced an intention to take over shares in Alsachimie joint venture from DOMO Chemicals. However, BASF's shareholders will receive a smaller dividend than last year due to the company's structural overhaul. In terms of the price target set by Citi, they maintain a neutral stance. Amid these fluctuations, BASF aims to divest non-core assets and is preparing its agricultural business for an
IPO.
BASF Stocks News Analytics from Tue, 17 Oct 2023 07:00:00 GMT to Sat, 19 Jul 2025 22:30:40 GMT -
Rating 3
- Innovation -5
- Information 7
- Rumor -5
